Should you buy Intuitive Surgical stock now?
The technical signal for Intuitive Surgical is currently Hold. Intuitive Surgical trades at $404.82 as of Oct 7, 2026. The technical analysis shows the following: MACD is positive (bullish trend) at 7.465 with rising momentum (signal: 6.926); RSI is at 58.0 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $476.34 points to 17.7% upside. This is a technical observation based on current data, not investment advice.
What is the price target for Intuitive Surgical stock?
The average analyst price target for Intuitive Surgical is $476.34. The current price is $404.82, which gives an upside of 17.7%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $428.71 and $523.97.
Is Intuitive Surgical a dividend stock?
No, Intuitive Surgical does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Intuitive Surgical stock?
Intuitive Surgical is rated as a stock in the risk category Moderate. the annual standard deviation is 36.8%, which classifies the stock as Moderate.
Is Intuitive Surgical overvalued?
No, Intuitive Surgical is considered undervalued based on the analyst price target (17.7% upside). Intuitive Surgical has the following valuation ratios: a P/E ratio of 46.1 (highly valued), a P/S ratio of 12.7, a P/B ratio of 7.8. The analyst price target suggests that the stock is undervalued by 17.7%.
Is Intuitive Surgical overbought?
No, Intuitive Surgical is not overbought. RSI is at 58.0 (neutral zone). The technical indicators show: RSI is at 58.0 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 3.2% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next Intuitive Surgical earnings report?
Intuitive Surgical reports its next earnings on October 20, 2026. The stock currently trades at $404.82. With a P/E ratio of 46.1, the market will be watching closely whether earnings meet expectations.
Is Intuitive Surgical shorted?
Yes, Intuitive Surgical is shorted with 2.3% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Intuitive Surgical stock?
No, insiders are not buying Intuitive Surgical shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 19 sales. On a net basis, 4,777,470 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 4,787,823 $ sold. Active sellers include Widman Fredrik, Brosius Mark, Ladd Amy L and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Intuitive Surgical a good stock?
Based on our total score, Intuitive Surgical is rated as a mediocre stock with a total score of 46 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 17/100, Quality: 87/100, Momentum: 35/100. In addition: analysts see 17.7% upside to the price target; technical signal: Hold. Whether Intuitive Surgical is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Intuitive Surgical stock?
The outlook for Intuitive Surgical based on current data: the average analyst price target is $476.34 (+17.7%); the next earnings report is due on Oct 20, 2026, which can move the price; the P/E ratio is 46.1 (high – the market expects growth). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Intuitive Surgical stock rising?
Intuitive Surgical is rising right now. The technical indicators show: the price is 3.2% above the 20-day average; MACD is positive with rising momentum (bullish signal); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Intuitive Surgical go?
The average analyst price target for Intuitive Surgical is $476.34, which corresponds to a potential gain of 17.7% from the current price of $404.82. The stock has traded between $328.57 and $603.88 over the last 52 weeks. The price is 33.0% below the 52-week high, which can indicate potential if the underlying fundamentals are intact. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Intuitive Surgical fall?
The stock has traded as low as $328.57 over the last 52 weeks — that is 18.8% below the current price of $404.82. The biggest decline (drawdown) in the same period was 45.6% from high to low. Within a year, the price typically swings about ±36.8% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Intuitive Surgical do?
Intuitive Surgical, Inc. makes equipment that helps doctors perform advanced surgery through small cuts instead of large ones. This is called minimally invasive surgery. The company mainly earns money by selling robotic surgical systems and the instruments used with them.
Its... The company belongs to the Healthcare sector, more specifically the Medical Instruments & Supplies industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Intuitive Surgical as an investment.
Did Intuitive Surgical raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Intuitive Surgical. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Intuitive Surgical making money or losing money?
Yes, Intuitive Surgical is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 28.5% — which is excellent. The operating margin (profit before interest and taxes) is 33.6%. At a P/E ratio of 46.1, you currently pay 46.1 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Intuitive Surgical go bankrupt?
The bankruptcy risk of Intuitive Surgical is rated as low. Altman Z2 (a model for assessing financial distress) is 12.06 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 7 — which is strong. Debt relative to equity is 14% (low). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Intuitive Surgical have a lot of debt?
No, Intuitive Surgical has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 14%. For the healthcare sector, anything below 80% counts as low debt. In healthcare, 80-150% is typical — large pharma companies carry debt for research and acquisitions. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
